109
Participants
Start Date
October 26, 2017
Primary Completion Date
February 7, 2022
Study Completion Date
July 31, 2024
Istituto Oncologico Veneto IRCCS, Padua
Roche Pharma AG
INDUSTRY
Istituto Oncologico Veneto IRCCS
OTHER